EVOLOCUMAB solution for injection (Repatha®▼) for the reduction of cardiovascular risk in patients with established atherosclerotic cardiovascular disease - Pan Mersey APC Skip to main content Help with accessibility Skip to main navigation

EVOLOCUMAB solution for injection (Repatha®▼) for the reduction of cardiovascular risk in patients with established atherosclerotic cardiovascular disease

Last Updated: 21 June 2018

Body System: Cardiovascular system

Grey

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing EVOLOCUMAB solution for injection (Repatha®▼) for the reduction of cardiovascular risk in patients with established atherosclerotic cardiovascular disease.